Featured
Modified red blood cells used for targeted cancer care
Genetically engineered red blood cells are treating autoimmune diseases and cancer for direct and personalized drug delivery.
Want to explore this innovation?
Start a free trial and get 7 days access to our global innovation database, AI-powered scouting tools, and expert insights. No commitment required
Start free trial View plans
If you are an existing member, login here